Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cidara Thera (CDTX)

Cidara Thera (CDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cidara Therapeutics Announces $105 Million Private Placement

CDTX : 17.45 (+15.41%)
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

CDTX : 17.45 (+15.41%)
Cidara Therapeutics: Q3 Earnings Snapshot

Cidara Therapeutics: Q3 Earnings Snapshot

CDTX : 17.45 (+15.41%)
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

CDTX : 17.45 (+15.41%)
Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

CDTX : 17.45 (+15.41%)
Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024

CDTX : 17.45 (+15.41%)
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

CDTX : 17.45 (+15.41%)
Cidara Therapeutics: Q2 Earnings Snapshot

Cidara Therapeutics: Q2 Earnings Snapshot

CDTX : 17.45 (+15.41%)
Cidara Therapeutics: Q1 Earnings Snapshot

Cidara Therapeutics: Q1 Earnings Snapshot

CDTX : 17.45 (+15.41%)
Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
META : 563.09 (-0.43%)
TSLA : 339.64 (-0.70%)
HAS : 61.91 (+0.10%)
TXN : 198.20 (+0.01%)
ODFL : 218.39 (+1.89%)
MSFT : 412.87 (-0.43%)
GOOGL : 167.63 (-4.74%)
MRK : 99.86 (+2.48%)
GILD : 89.76 (+1.27%)
CAT : 389.59 (+2.12%)

Barchart Exclusives

Recent Corn Rally Artificially Propped Up – What’s Next?
Corn prices appeared to have finally found a bottom from the summer sell-off. Speculators were short the market in record numbers until late August, when they began buying back contracts, convincing some that the harvest seasonal low may be in. Then, exports increased in the last few weeks, and prices rallied more. While the bearish fundamentals of 1.9 billion carry-out and the massive amount of unpriced corn still linger, there isn’t much hope for a significant price rally yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar